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Dear Sir,
After a careful reading of the paper by Kim et al1 where they report on
a thioredoxin-related protein-1 (TRP-1) induced by prostaglandin E2, I felt
compelled to bring to your attention several concerns on the results and
conclusions raised in this work.
Although the authors state three times throughout their paper that
TRP-1 is a variant of the previously described TMX-2/CGI-31 protein2 they
do not provide any DNA or protein sequence comparison to illustrate the
degree of homology between both variants. When attempting to perform
this comparison myself I found that TRP-1 DNA or protein sequences are
not available at GenBank and two email requests to the corresponding
author of the paper resulted in no reply. Therefore, the only alternative
available was to type myself the complete mRNA sequence as published in
the printed version and the resulting comparisons are shown in Figure 1 at
the mRNA level (95.1% identity) and in Figure 2 at the protein level (92.2%
identity). The TRP-1 and TMX-2/CGI-31 mRNAs mainly differ at two
different regions centered at nucleotides 552 and 840 (Figure 1, based on
TMX-2/CGI-31 nucleotide numbers) both within the ORF. The most striking
result of these nucleotide changes is the conversion of the protein
sequence WSNDC to WCGPC, which is the canonical sequence of
thioredoxins active site3. This feature prompted the authors to name
thioredoxin-related protein-1 (TRP-1) to the new variant.
However, the existence of this variant is not sustained either by the
available databases or experimental data provided. First, there are none
EST sequences that code for the TRP-1 variant. Second, a detailed
inspection of the human genomic databases does not identify any
sequence that would give rise to this variant by alternative splicing. Third,
the authors use the complete TRP-1 cDNA as probe for Northern blots to
identify a 1.7 kb band induced by PGE2 treatment. This size is identical to
that reported previously for TMX-2/CGI-312 and, given the high homology
between the two mRNAs, one cannot conclude from this approach that the
1.7 kb band corresponds to TRP-1 and not to TMX-2/CGI-31. Similarly, as
the same probe is used to determine the differential expression of TRP-1
mRNA in normal versus cancer tissues, again it is not possible to conclude
that the difference pertains to TRP-1 and not to TMX-2/CGI-31. Fourth, the
authors use real-time quantitative PCR to corroborate the PGE2 induction
of TRP-1 mRNA shown by northern blot. However, the primers used for this
approach are centered at position 89 (forward primer) and 429 (reverse
primer) and their sequences at these positions are identical for both TRP-1
and TMX-2/CGI-31 variants. Therefore, real-time PCR using the primers
described by Kim et al. cannot discriminate which variant is induced by
PGE2 treatment.
Taken together, I conclude that there is no physical evidence of the
TRP-1 variant being coded by the human genome and expressed in the
experimental set up described by Kim et al. Thus, a plausible explanation
for the isolation of TRP-1 might be as an aberrant product derived from the
treatment, the technique or the cell lines used in this work. An irrefutable
demonstration of the existence of TRP-1 would come from real-time PCR
using specific primers unique for TRP-1 and designed at the two regions
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Figure Legends
Figure 1. Comparison of TMX-2/CGI-31 and TRP-1 mRNA sequences.
The TRP-1 nucleotides that differ from those of TMX-2/CGI-31 are boxed.
The ORF is shadowed and the primers used for real-time PCR are
indicated by arrows.
Figure 2. Comparison of TMX-2/CGI-31 and TRP-1 protein sequences.
The TRP-1 residues that differ from those of TMX-2/CGI-31 are boxed. The
thioredoxin active site of TRP-1 is shadowed.
